10 Although not statistically significant, we observed a slight trend towards higher response rates in solar urticaria (89%), delayed pressure urticaria (79%), heat urticaria (75%), cholinergic urticaria (74%) and cold urticaria (71%) compared to the other subtypes.
← all excerpts
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.
1
—
—